← All Sponsors
SPONSOR

Tizona Therapeutics, Inc

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Cancer
NCT04485013 Phase 1
Recruiting

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Cancer
United States View Trial →